RxDoctor Payments Data

Georgios Poniros, DPM

Podiatrist · Auburn, MANPI 1083671077

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $393 and has fallen 53.0% since, to $185 in 2025.

$1,536in general payments, 2019–2025

Across 45 payments — averaging $34.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fusion Orthopedics USA, LLC$251
  • Bioventus LLC$210
  • Organogenesis Inc.$206
  • Treace Medical Concepts, Inc.$137
  • Medtronic$98
  • Musculoskeletal Transplant Foundation Inc.$93
  • plus $540 from 20 others

What the payments were for

  • Food & beverage$1,536100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,536 in reported general payments places this provider in the 70th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$154,463
Medicare patients
460
Services billed
1,468

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole247$3,933
Doxycycline Monohydrate36$485
Terbinafine Hcl37$309
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen43$202
Ammonium Lactate17$175
Ibuprofen14$132
Prednisone47$119
Meloxicam22$40

Paid to pharmacies, not to this prescriber.

Other podiatrist in Auburn

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →